...
首页> 外文期刊>Orthopaedic surgery >Sternal Tumor Resection and Reconstruction with Titanium Mesh: a Preliminary Study
【24h】

Sternal Tumor Resection and Reconstruction with Titanium Mesh: a Preliminary Study

机译:胸骨肿瘤切除与钛网重建的初步研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective To explore the clinical efficacy and complications of treating sternal tumors by resection and titanium mesh thoracic reconstruction. Methods This retrospective analysis of eight patients with sternal tumors treated in the Department of Orthopedic Surgery at the First Affiliated Hospital of Zhengzhou University from January 2008 to June 2012 included five men and three women aged 37–66 years (mean, 50.4 years). The histological diagnoses were chondrosarcoma (two cases), osteosarcoma (one), malignant fibrous histiocytoma (two), eosinophilic granuloma (one) and sternal metastasis from breast cancer (two). The tumors were invading the manubrium sterni (three cases), manubrium sterni and body (three) and sternal body (two). All patients underwent needle or incisional biopsy prior to sternal tumor resection and titanium mesh thoracic reconstruction. Results All patients were followed for 9 months to 4 years. There were no intraoperative complications or operative or postoperative deaths. One patient developed a deep wound hematoma 1 week postoperatively; incisional drainage and debridement resulting in healing within 2 weeks. There was no loosening or exsertion of the titanium mesh and no patients developed respiratory complications or thoracic deformity. One patient with malignant fibrous histiocytoma died of lung metastases 9 months postoperatively, another with malignant fibrous histiocytoma died of liver metastases 14 months postoperatively; the remaining patients survived without tumor recurrence. Conclusion Titanium mesh chest reconstruction after sternal tumor resection has the advantages of simplifying the procedure, achieving a good shape and having few complications. Titanium mesh is an ideal material for reconstruction of the sternum.
机译:目的探讨通过切除和钛网胸腔重建术治疗胸骨肿瘤的临床疗效和并发症。方法回顾性分析2008年1月至2012年6月在郑州大学第一附属医院骨外科收治的8例胸骨肿瘤患者,其中男5例,女3例,年龄37-66岁(平均50.4岁)。组织学诊断为软骨肉瘤(2例),骨肉瘤(1例),恶性纤维组织细胞瘤(2例),嗜酸性肉芽肿(1例)和乳腺癌的胸骨转移(2例)。肿瘤侵及手腕骨(3例),手腕骨与身体(3例)和胸骨(2例)。所有患者均在胸骨肿瘤切除术和钛网胸腔重建术前进行了针或切开活检。结果所有患者均获随访9个月至4年。没有术中并发症或手术或术后死亡。一名患者术后1周发生了深部伤口血肿;切开引流和清创术导致2周内愈合。钛网没有松动或消失,也没有患者出现呼吸系统并发症或胸廓畸形。一名恶性纤维组织细胞瘤患者术后9个月死于肺转移,另一名恶性纤维组织细胞瘤患者术后14个月死于肝转移;其余患者存活下来,没有肿瘤复发。结论胸骨肿瘤切除术后钛网片重建术具有操作简单,外形好,并发症少等优点。钛网是重建胸骨的理想材料。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号